Living with Spinal Muscular Atrophy: Genetic Testing, Therapy, and More

About this episode

Andrew Cherico shares his experience with spinal muscular atrophy and discusses treatment options with Dr. John W. Day.

Andrew Cherico, a student at the University of Central Florida, Orlando, FL, discusses his experience living with spinal muscular atrophy (SMA), the impacts of available treatments, and how the condition intersects with his passion for sports journalism. He is joined by John W. Day, MD, PhD, Professor of Neurology and Pediatrics, Director, Division of Neuromuscular Medicine at Stanford University School of Medicine, and Co-Director of Stanford’s Neuro IGNITE Center, Stanford, CA, who describes the importance of genetic testing, the landscape of available SMA treatments, and the significance of the newly approved one-time gene therapy Itvisma (onasemnogene abeparvovec-brve; Novartis, East Hanover, NJ).

People in this episode

Guests: Andrew Cherico, John W. Day, MD, PhD

Topics covered

• Spinal Muscular Atrophy
• Genetic Testing
• Therapies
• Sports Journalism
• Patient Experience

Keywords

• spinal muscular atrophy
• genetic testing
• Itvisma
• sports journalism
• neuromuscular medicine

Mentioned in this episode

Organizations: University of Central Florida, Stanford University School of Medicine, Stanford’s Neuro IGNITE Center, Novartis

Products: Itvisma

Places: Orlando, FL, Stanford, CA

More episodes of Amplifying the Patient Journey

• The Power of Movement for Parkinson Disease · May 8, 2026 · 22 min
• Emma’s Journey: A Mother’s Hope in the Face of Dravet Syndrome · November 13, 2025 · 19 min
• Learning, Laughing, and Living with Multiple Sclerosis · October 21, 2025 · 28 min
• Parkinson Disease Therapy: Lifestyle Interventions to Optimize Care · October 21, 2025 · 25 min
• Redefining the Doctor-Patient Partnership: What a Physician-Patient Can Teach Us About Parkinson Disease Care · October 17, 2025 · 13 min
• Mastering Migraine · May 7, 2025 · 25 min